These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Therapeutic investigations with venosan in veinous disease in the legs (author's transl)]. Juon M, Messelhäuser I. Schweiz Rundsch Med Prax; 1976 Jun 15; 65(24):755-8. PubMed ID: 981190 [No Abstract] [Full Text] [Related]
3. [Dosage of O-beta hydroxyethylrutoside in chronic venous insufficiency]. Stemmer R, Furderer CR. Phlebologie; 1986 Jun 15; 39(4):995-1003. PubMed ID: 3562569 [Abstract] [Full Text] [Related]
12. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs]. Pedersen FM, Hamberg O, Sørensen MD, Neland K. Ugeskr Laeger; 1992 Sep 14; 154(38):2561-3. PubMed ID: 1413183 [Abstract] [Full Text] [Related]
13. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK. Pulvertaft TB. Vasa; 1983 Sep 14; 12(4):373-6. PubMed ID: 6362258 [No Abstract] [Full Text] [Related]
17. [Effect of venous drugs on venous capacity and capillary filtration in lower extremities in patients with chronic venous insufficiency (author's transl)]. Roztocil K, Prerovský I, Oliva I, Hálová J. Cas Lek Cesk; 1977 Apr 08; 116(14):429-31. PubMed ID: 120759 [No Abstract] [Full Text] [Related]
18. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function. Cappelli R, Pecchi S, Oberhauser V, Forconi S, Di Perri T. Int J Clin Pharmacol Res; 1987 Apr 08; 7(4):291-9. PubMed ID: 3596872 [Abstract] [Full Text] [Related]